Intellectual Property India Publishes Patent Application for Process For The Preparation Of N-[(1s,2e)-1-Cyclopropyl-3-(methanesulfonyl)prop-2-En-1-Yl]-2-(1,1- Difluoroethyl)-4-Phenoxypyrimidine-5-Carboxamide

MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202617091981 A) filed by Vividion Therapeutics, Inc. on July 29, 2026, for Process For The Preparation Of N-[(1s,2e)-1-Cyclopropyl-3-(methanesulfonyl)prop-2-En-1-Yl]-2-(1,1- Difluoroethyl)-4-Phenoxypyrimidine-5-Carboxamide.

Inventors include Adam, Jean-Michel; Christ, Markus Heinrich; Cinqualbre, Josphine Eliette Franoise; Ge, Yonghui; James, Philippe Jean-Paul; Pfeifer, Eugen; Tagliente, Orazio; Xu, Zhixiang; and Zhang, Fugui.

The application for the patent was published on October 30, 2026, under issue no. 44/2026.

Abstract: The present invention relates to a process for the preparation of compound (I), or a pharmaceutically acceptable salt thereof...